Drug news
NICE recommends Forxiga (dapagliflozin) with metformin and a sulfonylurea as triple therapy fro type 2 daibetes= AstarZeneca.
The National Institute for Health and Care Excellence (NICE) has recommended Forxiga (dapagliflozin) from AstraZeneca as part of a triple therapy treatment for Type 2 Diabetes which will include metformin and a sulfonylurea.